SARCLISA SIMPRE Trademark

Trademark Overview

On Tuesday, December 12, 2023, a trademark application was filed for SARCLISA SIMPRE with the United States Patent and Trademark Office. The USPTO has given the SARCLISA SIMPRE trademark a serial number of 98310452. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, May 13, 2025. This trademark is owned by Sanofi. The SARCLISA SIMPRE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for use in oncology; pharmaceutical preparations for the treatment of multiple myeloma
sarclisa simpre

General Information

Serial Number98310452
Word MarkSARCLISA SIMPRE
Filing DateTuesday, December 12, 2023
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, May 13, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 18, 2025

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for use in oncology; pharmaceutical preparations for the treatment of multiple myeloma
Translation of Words in MarkThe English translation of "SIMPRE" in the mark is "yes".

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, December 12, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSanofi
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressParis 75017
FR
Party NameSanofi
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressParis 75017
FR

Trademark Events

Event DateEvent Description
Tuesday, December 12, 2023NEW APPLICATION ENTERED
Wednesday, June 26, 2024PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Wednesday, June 26, 2024ASSIGNED TO LIE
Thursday, July 11, 2024ASSIGNED TO EXAMINER
Thursday, July 18, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, July 18, 2024NON-FINAL ACTION WRITTEN
Wednesday, December 27, 2023TEAS VOLUNTARY AMENDMENT RECEIVED
Friday, March 15, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, August 26, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, August 26, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, August 26, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, October 30, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, October 30, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, July 18, 2024NON-FINAL ACTION E-MAILED
Tuesday, October 8, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, October 8, 2024NON-FINAL ACTION E-MAILED
Tuesday, October 8, 2024NON-FINAL ACTION WRITTEN
Wednesday, October 30, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, November 16, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, November 16, 2024NON-FINAL ACTION WRITTEN
Saturday, November 16, 2024NON-FINAL ACTION E-MAILED
Tuesday, January 14, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, February 21, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, February 25, 2025LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, January 14, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, January 14, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, March 18, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, March 12, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 18, 2025PUBLISHED FOR OPPOSITION
Tuesday, May 13, 2025NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, June 30, 2025TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Monday, June 30, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, June 30, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, June 30, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, June 30, 2025TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

Related Keywords

simpre sarclisa preparations pharmaceutical treatment myeloma multiple cancer oncology